[ad_1]
(Graph = E today)
On the 9th, the increase keywords are #Samsung Electronics #Kia Motors #Pebi Pharma #Seegene #Hyundai Motors.
Samsung Electronics is the most widely bought stock by individual investors among national equities this year. On the 11th of last month, Samsung Electronics’ stock price closed at 91,000 won, reaching the highest closing price, but has since fallen to 80,000 won.
However, a positive outlook remains for the semiconductor industry. Researchers Geun-Chang Noh and Chan-Ho Park of Hyundai Motor Securities said: “In light of increased demand due to the expansion of telecommuting, increased demand for the cloud and increased demand for cloud computing, edge (a method of processing part of the data through a small distributed server) of telecommunications companies), the prices of server DRAM will increase. It is also necessary to open the possibility to significantly exceed the market forecast. “
The day before, Hyundai Motor Group shares plunged at the same time on news that negotiations for an autonomous electric vehicle ‘Apple Car’ between Hyundai Motor Group and Apple were broken. However, individual investors were found to contain around 600 billion won of Hyundai Motor Group shares, such as Kia Motors, Hyundai Mobis, Hyundai Glovis, and Hyundai Motors.
Given the strong fundamentals of Hyundai Motor and Kia Motors’ improving earnings, the drop in share price can be interpreted as an opportunity to buy at a low price.
In the stock market, the news of the cessation of negotiations between Hyundai Motor Group and Apple may act as a correction factor for the share price in the short term, but he agreed that there were no changes in the solid fundamentals. NH Investment & Securities researcher Cho Soo-hong said: “In the recent stock market, short-term share price volatility will increase because expectations about the possibility of cooperation with Hyundai Motor Group and Apple have been high “.
Phoebe Fava (Prestige Bio Pharma) is a new stock that has been recently listed. The day before, we posted an upper bound to solve the overhang problem (bubbles waiting to sell).
On the 5th, PB Pharma’s trading volume was 4,1481126 shares. This is 1.5 times greater than the total number of floating shares (26,263,475 shares). A securities industry official said: “After listing, the available distribution amount was 12.7 million, 356 shares (21.13% of total listed shares), so the cantilever issue was initially low It will have a positive effect on the future flow of stock prices. “
Seegene was fined for violating accounting rules. According to the Securities and Futures Commission, Seegene voluntarily carried excessive quantities of products that exceed the actual order volume from 2011 to 2019 from the agency, and recognized all of them as sales, and over or under-sales, cost of sales and related . goods.
The Jeungsun Committee decided to impose a fine on Seegene (final decision of the Financial Services Commission), 3 years of appointment of an auditor, recommendation of dismissal and 6 months of suspension of work and improvement of internal control.
